When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Robert F. Kennedy, President Donald Trump's nominee for health and human services secretary, survives two heated confirmation hearings but still faces crucial Senate votes.

Kennedy has tried to recast his anti-vaccine extremism as an honest effort to illuminate what he claims is unsettled science (it’s not). He insists he’s not trying to take away anyone’s shots; he’s ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

Robert F. Kennedy Jr.'s views on vaccines and his nomination for HHS secretary were questioned again in a second Senate hearing.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.

Controversial Health and Human Services nominee Robert F. Kennedy Jr. was back on Capitol Hill Thursday morning to answer ...

In a series of aggressive, rapid-fire questions to Robert F. Kennedy Jr. about his plans to replace career scientists at the ...